Activated Janus Kinase 3 expression not by activating mutations identified in Natural Killer/T-cell lymphoma

JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma

(2013) A Bouchekioua et al.   LEUKEMIA

Rare occurrence ofJAK3mutations in natural killer cell neoplasms in Japan

(2013) Hiroshi Kimura et al.   LEUKEMIA & LYMPHOMA

Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

(2012) Ghee Chong Koo et al.   Cancer Discovery

Janus kinase 3: the controller and the controlled

(2011) W. Wu et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma

(2011) N. E. Elliott et al.   BLOOD

Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses

(2011) K. Karube et al.   BLOOD

Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models

(2009) M. G. Cornejo et al.   BLOOD